These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Drug treatment options for multidrug-resistant tuberculosis. Patel K Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123 [No Abstract] [Full Text] [Related]
29. Global spotlight falls on tuberculosis. Das P Lancet Infect Dis; 2004 Apr; 4(4):188. PubMed ID: 15072057 [No Abstract] [Full Text] [Related]
30. Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis. Chakaya JM; Marais B; du Cros P; Ntoumi F; Mfinanga S; Kapata N; Hasnain SE; Nathavitharana R; Zumla A Lancet Respir Med; 2020 Apr; 8(4):334-335. PubMed ID: 32113573 [No Abstract] [Full Text] [Related]
31. Multi-drug-resistant central nervous system tuberculosis. Murthy JM Neurol India; 2012; 60(2):143-5. PubMed ID: 22626692 [No Abstract] [Full Text] [Related]
32. M tuberculosis drug resistance in AIDS. Durrheim DN; Levin J; Weyer K Lancet; 1997 Jan; 349(9044):61; author reply 61-2. PubMed ID: 8988144 [No Abstract] [Full Text] [Related]
33. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. Yew WW; Chang KC; Chau CH J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903 [No Abstract] [Full Text] [Related]
34. Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated. Yassin MA; Jaramillo E; Wandwalo E; Falzon D; Scardigli A; Kunii O; Weyer K Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331045 [No Abstract] [Full Text] [Related]
35. Drug development for tuberculosis: the missing ingredient. Reichman LB; Fanning A Lancet; 2001 Jan; 357(9251):236. PubMed ID: 11213133 [No Abstract] [Full Text] [Related]
36. AIDS and tuberculosis - a lethal combination. Ojcius D Nat Rev Microbiol; 2004 Nov; 2(11):858. PubMed ID: 15523763 [No Abstract] [Full Text] [Related]
37. The impact of drug resistance on the global tuberculosis epidemic. Schluger NW Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153 [No Abstract] [Full Text] [Related]
38. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
39. Multidrug resistant tuberculosis: trends and control. Prasad R; Gupta N; Singh M Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197 [TBL] [Abstract][Full Text] [Related]
40. A threat to decentralised care for drug-resistant tuberculosis. Gray AT; Boyles T; Luedtke S; Sossen B; Birjovanu G; Kostkova P; Hughes J; Esmail H Lancet Respir Med; 2020 Oct; 8(10):950-952. PubMed ID: 33007284 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]